参考文献/References:
[1]Gagner M,Lacroix A,Bolté E.Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma.N Engl J Med,1992,327(14):1033.
[2]Ji C,Lu Q,Chen W,et al.Retrospective comparison of three minimally invasive approaches for adrenal tumors:perioperative outcomes of transperitoneal laparoscopic,retroperitoneal laparoscopic and robotassisted laparoscopic adrenalectomy.BMC Urol,2020,20(1):66.
[3]Aporowicz M,Domosawski P,Czopnik P,et al.Perioperative complications of adrenalectomy:12 years of experience from a single center/teaching hospital and literature review.Arch Med Sci,2018,14(5):1010-1019.
[4]Fiori C,Amparore D,Checcucci E,et al.Predictors of intra and postoperative complications in laparoscopic adrenalectomy:results of a uni and multivariate analysis in a single centre.Eur Urol Suppl,2019,18(9):e3348.
[5]Sung TY,Tennakoon L,Alobuia WM,et al.Factors associated with postoperative complications and costs for adrenalectomy in benign adrenal disorders.Surgery,2022,171(6):1519-1525.
[6]Kstek M,Aygün N,Uluda M.Laparoscopic approach to the adrenal masses: singlecenter experience of five years.Sisli Etfal Hastan Tip Bul,2020,54(1):52-57.
[7]Chiu A,VargasPinto S,AbouAzar S,et al.Contemporary experience of posterior retroperitoneoscopic adrenalectomy in the US.J Am Coll Surg,2021,232(6):815-821.
[8]Chen Y,Scholten A,ChomskyHiggins K,et al.Risk factors associated with perioperative complications and prolonged length of stay after laparoscopic adrenalectomy.JAMA Surg,2018,153(11):1036-1041.
[9]Sforza S,Minervini A,Tellini R,et al.Perioperative outcomes of robotic and laparoscopic adrenalectomy:a large international multicenter experience.Surg Endosc,2021,35(4):1801-1807.
[10]Brunaud L,NguyenThi PL,Mirallie E,et al.Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma:a multicenter retrospective analysis in 225 patients.Surg Endosc,2016,30(3):1051-1059.
[11]刘建勇,赖世聪,宋新达,等.腹腔镜肾上腺肿瘤切除术后并发症发生及住院时间延长的相关危险因素.微创泌尿外科杂志,2020,9(5):294-299.
[12]Cicek MC,Gunseren KO,Senol K,et al.Is 6 cm diameter an upper limit for adrenal tumors to perform laparoscopic adrenalectomy?J Laparoendosc Adv Surg Tech A,2021,31(3):301-305.
[13]Prakobpon T,SantiNgamkun A,Usawachintachit M,et al.Laparoscopic transperitoneal adrenalectomy in the large adrenal tumor from single center experience.BMC Surg,2021,21(1):68.
[14]Kong H,Li N,Tian J,et al.Risk predictors of prolonged hypotension after open surgery for pheochromocytomas and paragangliomas.World J Surg,2020,44(11):3786-3794.
[15]Wu S,Chen W,Shen L,et al.Risk factors for prolonged hypotension in patients with pheochromocytoma undergoing laparoscopic adrenalectomy:a singlecenter retrospective study.Sci Rep,2017,7(1):5897.
[16]Araki S,Kijima T,Waseda Y,et al.Incidence and predictive factors of hypoglycemia after pheochromocytoma resection.Int J Urol,2019,26(2):273-277.
[17]Prudhomme T,Roumiguié M,Gas J,et al.Comparison between retroperitoneal and transperitoneal laparoscopic adrenalectomy:are both equally safe?J Visc Surg,2021,158(3):204-210.
[18]Christakis I,Ng CS,Chen C,et al.Operation duration and adrenal gland size,but not BMI,are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases.Surgery,2019,165(3):637-643.
[19]Agcaoglu O,Akbas M,Ozdemir M,et al.The impact of body mass index on perioperative outcomes of robotic adrenalectomy:an update.Surg Innov,2019,26(6):687-691.
[20]Danwang C,Agbor VN,Bigna JJ.Obesity and postoperative outcomes of the patients with laparoscopic adrenalectomy:a systematic review and metaanalysis.BMC Surg,2020,20(1):194.
[21]Bai S,Yao Z,Zhu X,et al.Risk factors for postoperative cardiovascular morbidity after pheochromocytoma surgery:a large single center retrospective analysis.Endocr J,2019,66(2):165-173.
[22]Manfredi M,Amparore D,Checcucci E,et al.Perioperative complication predictors in laparoscopic adrenalectomy a single centre multivariate analysis.Eur Urol Open Sci,2020,19(Suppl 2):e911.
[23]朱伟,王少刚,杜广辉,等.老年嗜铬细胞瘤患者围手术期临床特点分析.中华老年医学杂志,2019,38(11):1278-1281.
[24]PisarskaAdamczyk M,Zawadzka K,Wickowski K,et al.Risk factors for hemodynamic instability during laparoscopic pheochromocytoma resection:a retrospective cohort study.Gland Surg,2021,10(3):892-900.
[25]Kong H,Li N,Tian J,et al.The use of doxazosin before adrenalectomy for pheochromocytoma:is the duration related to intraoperative hemodynamics and postoperative complications?Int Urol Nephrol,2020,52(11):2079-2085.
[26]AraujoCastro M,Garcia Centeno R,LópezGarcía MC,et al.Risk factors for intraoperative complications in pheochromocytomas.Endocr Relat Cancer,2021,28(11):695-703.
[27]Bittner JGT,Gershuni VM,Matthews BD,et al.Risk factors affecting operative approach,conversion,and morbidity for adrenalectomy:a singleinstitution series of 402 patients.Surg Endosc,2013,27(7):2342-2350.
[28]Inversini D,Manfredini L,Galli F,et al.Risk factors for complications after robotic adrenalectomy:a review.Gland Surg,2020,9(3):826-830.
[29]龚灿生,李艳珍,杨瑞芝,等.术中血流动力学波动对嗜铬细胞瘤和副神经节瘤患者术后并发症的影响.中华高血压杂志,2021,29(12):1266-1271.
[30]Lindeman B,Hashimoto DA,Bababekov YJ,et al.Fifteen years of adrenalectomies:impact of specialty training and operative volume.Surgery,2018,163(1):150-156.
[31]Park HS,Roman SA,Sosa JA.Outcomes from 3144 adrenalectomies in the United States:which matters more,surgeon volume or specialty?Arch Surg,2009,144(11):1060-1067.
[32]Dralle H.Fewer complications with more than six adrenalectomies per year.Chirurg,2019,90(Suppl 2):96.
[33]Coste T,Caiazzo R,Torres F,et al.Laparoscopic adrenalectomy by transabdominal lateral approach:20 years of experience.Surg Endosc,2017,31(7):2743-2751.
[34]Pdziwiatr M,Wierdak M,Ostachowski M,et al.Single center outcomes of laparoscopic transperitoneal lateral adrenalectomy:lessons learned after 500 cases.A retrospective cohort study.Int J Surg,2015,20(8):88-94.